Related Experiment Video
Updated: Jan 29, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Kaempferol inhibits osteoclast differentiation and bone resorption by targeting the TNF-α/NF-κB and SRC/PI3K/AKT
Qiting Yu1, Taiping Jiang2, Yunpeng Zhao1
1Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550000, China.
Insights
Kaempferol effectively inhibits osteoclast differentiation and bone resorption by targeting key signaling pathways, offering a potential therapeutic strategy for osteoporosis. This study elucidates its dual action against osteoclastogenesis and oxidative stress.
Area of Science:
- Pharmacology and Traditional Chinese Medicine
- Molecular Biology and Biochemistry
- Bone Biology and Osteoporosis Research
Background:
- Osteoporosis is a significant skeletal disorder characterized by decreased bone mass and increased fracture risk.
- Kaempferol, a natural flavonoid, shows promise in regulating osteoporosis, but its precise molecular mechanisms require detailed investigation.
- Understanding kaempferol's targets and pathways is crucial for developing novel anti-osteoporotic therapies.
Purpose of the Study:
- To elucidate the molecular mechanism of kaempferol's anti-osteoporotic effects using network pharmacology and experimental validation.
- To identify key targets and signaling pathways modulated by kaempferol in the context of osteoporosis.
- To evaluate the inhibitory effects of kaempferol on osteoclast differentiation and oxidative stress.
Main Methods:
- Network pharmacology approach utilizing TCMSP and SwissTargetPrediction databases to identify kaempferol targets.
- Protein-protein interaction (PPI) network analysis, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment.
- Experimental validation in RAW 264.7 cells, including cell viability assays, osteoclast differentiation and resorption assessments, oxidative stress marker analysis, and molecular mechanism studies (RT-qPCR, Western blotting).
Main Results:
- Network pharmacology identified 37 core targets and highlighted kaempferol's high binding affinity with AKT, NF-κB, PI3K, SRC, and TNF-α.
- Kaempferol significantly increased RAW 264.7 cell viability, dose-dependently inhibited osteoclast differentiation and bone resorption, and reduced oxidative stress markers (ROS, MDA) while increasing SOD activity.
- Kaempferol downregulated osteoclastogenesis-related genes (RANK, CSF1R, c-Fos, CTSK, MMP-9) and inhibited the TNF-α/NF-κB and SRC/PI3K/AKT signaling pathways.
Conclusions:
- Kaempferol demonstrates dual inhibitory effects on osteoclast differentiation and oxidative stress, validating its anti-osteoporotic potential.
- The anti-resorptive activity of kaempferol is attributed to the coordinated inhibition of RANK/M-CSF signaling and downstream TNF-α/NF-κB and SRC/PI3K/AKT pathways.
- These findings provide a comprehensive understanding of kaempferol's molecular mechanisms, supporting its development as a therapeutic agent for osteoporosis.
Abstract:
Kaempferol exerts an important regulatory effect on osteoporosis, while its mechanism has not been fully elucidated. This study aimed to investigate the molecular mechanism underlying the anti-osteoporotic effect of kaempferol. Potential targets of kaempferol (197 genes) were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and SwissTargetPrediction databases. Meanwhile, osteoporosis-related targets (986 non-redundant genes) were compiled from disease-specific databases. Protein-protein interaction (PPI) network analysis was performed to identify 37 core targets. Subsequent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses revealed 3,295 biological processes and 205 signaling pathways, respectively. Molecular docking results demonstrated that kaempferol has high binding affinities with AKT, NF-κB, PI3K, SRC, and TNF-α. For experimental validation, RAW 264.7 cells were used: cell viability was assessed via the Cell Counting Kit 8 (CCK8) assay; osteoclast differentiation and bone resorption were evaluated through tartrate-resistant acid phosphatase (TRAP) staining and toluidine blue staining, respectively; oxidative stress markers (reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA) were measured by enzyme-linked immunosorbent assay (ELISA); and molecular mechanisms were analyzed using quantitative real-time polymerase chain reaction (RT-qPCR) and Western blotting to detect osteoclast-related molecules (RANK, CSF1R, c-Fos, CTSK, and MMP-9) and signaling pathway proteins. Kaempferol significantly increased the viability of RAW 264.7 cells (P < 0.05). TRAP and toluidine blue staining showed dose-dependent decreases in osteoclast number and resorption area (P < 0.05). Additionally, kaempferol concentration-dependently reduced ROS and MDA levels while increasing SOD activity. It also significantly downregulated the expression of osteoclastogenesis-related genes (RANK, CSF1R, c-Fos, CTSK, and MMP-9; P < 0.05) and inhibited the activation of the TNF-α/NF-κB and SRC/PI3K/AKT signaling pathways. The predictions from network pharmacology were validated experimentally, confirming that kaempferol exerts dual inhibitory effects on osteoclast differentiation and oxidative stress. The coordinated inhibition of RANK/M-CSF signaling and its downstream TNF-α/NF-κB and SRC/PI3K/AKT pathways underpins the anti-resorptive activity of kaempferol..
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Osteoclasts in Bone Remodeling
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

